ASX - By Stock
|
TTT |
Re:
Ann: Completion of Retail Entitlement Offer
|
|
scopeinn
|
40 |
13K |
0 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
40
|
13K
|
0
|
|
ASX - By Stock
|
BNO |
Re:
Ann: Bionomics announces voluntary delisting from ASX
|
|
scopeinn
|
9 |
6.1K |
2 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
9
|
6.1K
|
2
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
scopeinn
|
15 |
3.9K |
0 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
15
|
3.9K
|
0
|
|
ASX - By Stock
|
OJC |
Re:
Ann: Hon. Jeff Kennett AC Appointed as Chairman
|
|
scopeinn
|
10 |
6.0K |
2 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
10
|
6.0K
|
2
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Funding Agreement with AXA Health UK
|
|
scopeinn
|
52 |
13K |
0 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Funding Agreement with AXA Health UK
|
|
scopeinn
|
52 |
13K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Funding Agreement with AXA Health UK
|
|
scopeinn
|
52 |
13K |
0 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
LVT |
Re:
Regal & AGM
|
|
scopeinn
|
22 |
8.8K |
0 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
22
|
8.8K
|
0
|
|
ASX - By Stock
|
PCK |
Re:
PainChek General Discussion
|
|
scopeinn
|
20K |
16M |
2 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
20K
|
16M
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Ceasing to be a substantial holder
|
|
scopeinn
|
20 |
9.1K |
14 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
20
|
9.1K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Becoming a substantial holder
|
|
scopeinn
|
56 |
16K |
4 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
56
|
16K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Second Supplementary Scheme Booklet
|
|
scopeinn
|
255 |
69K |
8 |
27/08/22 |
27/08/22 |
ASX - By Stock
|
255
|
69K
|
8
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Retirement of CEO
|
|
scopeinn
|
51 |
17K |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
51
|
17K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Second Supplementary Scheme Booklet
|
|
scopeinn
|
255 |
69K |
7 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
255
|
69K
|
7
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Company Update
|
|
scopeinn
|
297 |
149K |
4 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
297
|
149K
|
4
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Company Update
|
|
scopeinn
|
297 |
149K |
9 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
297
|
149K
|
9
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
2 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
2
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
0
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
0
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
0
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
1 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
1
|
|
ASX - By Stock
|
LVT |
Re:
Ann: LiveTiles announces voluntary delisting
|
|
scopeinn
|
146 |
79K |
1 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
146
|
79K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
scopeinn
|
62 |
17K |
6 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
62
|
17K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
scopeinn
|
466 |
159K |
10 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
466
|
159K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
scopeinn
|
466 |
159K |
7 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
466
|
159K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Psychological Conditioning
|
|
scopeinn
|
131 |
27K |
15 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
131
|
27K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of First Court Hearing
|
|
scopeinn
|
44 |
17K |
4 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
44
|
17K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
scopeinn
|
126 |
37K |
5 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
scopeinn
|
126 |
37K |
14 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
scopeinn
|
132 |
46K |
13 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
132
|
46K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Suspend Trade of Rap Shares
|
|
scopeinn
|
11 |
5.2K |
16 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
11
|
5.2K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
scopeinn
|
93 |
31K |
1 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
scopeinn
|
93 |
31K |
1 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
19 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
124K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
9 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
124K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
3 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
124K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
6 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
124K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
124K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
scopeinn
|
425 |
124K |
18 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
124K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
scopeinn
|
38 |
19K |
3 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
38
|
19K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
scopeinn
|
38 |
19K |
2 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
38
|
19K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
scopeinn
|
38 |
19K |
13 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
38
|
19K
|
13
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
scopeinn
|
118 |
37K |
4 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
37K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
sb has been keep spending couple millions dollars in this stock!!!
|
|
scopeinn
|
24 |
8.2K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
24
|
8.2K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
sb has been keep spending couple millions dollars in this stock!!!
|
|
scopeinn
|
24 |
8.2K |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
24
|
8.2K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
scopeinn
|
377 |
142K |
7 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
377
|
142K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
scopeinn
|
377 |
142K |
24 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
377
|
142K
|
24
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
scopeinn
|
377 |
142K |
15 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
scopeinn
|
377 |
142K |
0 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
142K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
scopeinn
|
92 |
43K |
5 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
92
|
43K
|
5
|
|